Page last updated: 2024-11-04

saccharin and Auricular Flutter

saccharin has been researched along with Auricular Flutter in 1 studies

Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.

Research Excerpts

ExcerptRelevanceReference
"Oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation."8.12Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. ( Aksoy, I; Al-Windy, N; Badings, E; Belardinelli, L; Camm, AJ; Crijns, HJGM; Elvan, A; Kowey, PR; Madhavapeddi, P; Ruskin, JN; Tuininga, YS; Van Gelder, IC, 2022)
"Oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation."4.12Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. ( Aksoy, I; Al-Windy, N; Badings, E; Belardinelli, L; Camm, AJ; Crijns, HJGM; Elvan, A; Kowey, PR; Madhavapeddi, P; Ruskin, JN; Tuininga, YS; Van Gelder, IC, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Crijns, HJGM1
Elvan, A1
Al-Windy, N1
Tuininga, YS1
Badings, E1
Aksoy, I1
Van Gelder, IC1
Madhavapeddi, P1
Camm, AJ1
Kowey, PR1
Ruskin, JN1
Belardinelli, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation[NCT03539302]Phase 2170 participants (Actual)Interventional2018-05-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for saccharin and Auricular Flutter

ArticleYear
Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm.
    Circulation. Arrhythmia and electrophysiology, 2022, Volume: 15, Issue:3

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Flecainide; Huma

2022